Neuromedin U

Overview

Neuromedin U (NMU) is a neuropeptide first isolated by Minamino and colleagues in 1985 from porcine spinal cord based on its ability to contract rat uterine smooth muscle — the "U" in neuromedin U reflects this uterus-contracting origin. It belongs to the broader family of "neuromedins" that includes neuromedin B, C, K (neurokinin B), L (neurokinin A), N, S, and U — a group of peptides originally identified through screening spinal cord extracts for smooth-muscle-active substances.

Mammalian NMU exists in two main mature forms: NMU-25 (25 amino acids, the dominant form in peripheral tissues and rat brain) and NMU-8 (8 amino acids, the dominant form in pig brain). Both forms share a conserved amidated C-terminal octapeptide that constitutes the receptor-binding pharmacophore.

Modern interest in NMU expanded dramatically when its receptors NMUR1 and NMUR2 were identified in 2000 and NMU was shown to profoundly suppress food intake when administered centrally. NMU knockout mice display obesity and hyperphagia, and transgenic overexpression produces a lean phenotype. This bidirectional phenotype established NMU as a key regulator of energy balance alongside leptin, neuropeptide Y, and ghrelin.

Structure/Sequence

Human NMU-25: FRVDEEFQGPIVSQNRRYFLFRPRN-NH₂

Human NMU-8 (C-terminal octapeptide): YFLFRPRN-NH₂

• Mature forms: NMU-25 (dominant peripheral), NMU-8 (C-terminal octapeptide, CNS-predominant in some species)
• Molecular weight: NMU-25 ~3,080 g/mol; NMU-8 ~1,110 g/mol
• Gene: NMU (chromosome 4q12)
• C-terminal amidation: Essential for receptor binding
• Conserved FLFRPRN motif: C-terminal heptapeptide essential for bioactivity
• Processing: Derived from a ~174-aa preproNMU precursor

The C-terminal amidated heptapeptide FLFRPRN is strictly required for activity; N-terminal extensions contribute to receptor subtype selectivity and pharmacokinetics but are not essential for agonism per se.

Mechanism of Action

Receptor Binding

NMU signals through two closely related GPCRs:

NMUR1 (FM-3, GPR66):

• Expressed predominantly in peripheral tissues — GI tract, genitourinary tract, immune cells
• Couples primarily to Gq/11
• Activates phospholipase C, increasing IP3 and calcium
• Mediates smooth muscle contraction and immune effects

NMUR2 (FM-4, TGR-1):

• Expressed predominantly in CNS — paraventricular nucleus, arcuate nucleus, brainstem
• Couples to Gq/11 and Gi/o
• Mediates central effects on feeding, stress, and circadian rhythm

Central Feeding Effects

• ICV NMU dramatically suppresses food intake
• Effects mediated primarily through NMUR2 in the paraventricular hypothalamus
• Increases corticotropin-releasing hormone (CRH) release
• Activates stress circuits (HPA axis)
• Suppresses body weight gain with chronic administration

Peripheral Smooth Muscle Effects

• Contracts uterine, ileal, bronchial, and vascular smooth muscle
• NMUR1-mediated
• Underlies the original bioassay that identified NMU

Immune Function

• NMU and NMUR1 expressed on Th2 cells, type 2 innate lymphoid cells (ILC2s), and mast cells
• Amplifies allergic and Th2 immune responses
• ILC2 expansion through NMU signaling contributes to airway inflammation in asthma models

Circadian and Stress Roles

• NMU expression shows circadian variation
• Mediates stress-induced thermogenesis and autonomic responses through central NMUR2

Bone and Energy Expenditure

• Central NMU increases energy expenditure
• Regulates bone mass through central effects

Research Summary

Common Discussion Topics

1. Two-receptor partitioning — The peripheral-NMUR1 vs central-NMUR2 distribution pattern is a textbook example of how a single peptide can dispatch distinct physiological programs through receptor subtype localization. Peripheral smooth muscle and immune effects are NMUR1; central feeding and stress effects are NMUR2.

2. Knockout obesity phenotype — NMU-/- mice gaining weight demonstrated that NMU is a tonic inhibitor of food intake under physiological conditions. This is a stronger phenotype than many appetite-regulating peptide knockouts, highlighting NMU's physiological importance.

3. Immune biology emergence — The discovery that NMU promotes ILC2 expansion and Th2 inflammation in 2017 established a new branch of NMU research, linking neuropeptide biology to tissue immunity and allergic disease in mechanistically specific ways.

4. Relationship to neuromedin S — Neuromedin S (NMS) is a related peptide sharing the C-terminal octapeptide of NMU and binding the same two receptors. The two peptides have overlapping but distinct physiological roles, with NMS more implicated in circadian and reproductive regulation.

5. Stress and anorexia — NMU's activation of CRH neurons and the HPA axis links it to stress-induced anorexia. The peptide may participate in the biology of appetite suppression during acute stress, distinct from metabolic appetite regulation.

Related Compounds

• Neurotensin — another gut-brain peptide with smooth muscle and feeding effects
• Neuropeptide Y — orexigenic counterpart in feeding circuits
• Ghrelin — peripheral hunger signal opposing NMU
• Leptin — satiety hormone acting in overlapping hypothalamic circuits